middle.news
How Will $2.6m Non-Dilutive Capital Accelerate Tryp’s TRP-8803 Trials?
8:37am on Tuesday 12th of August, 2025 AEST
•
Healthcare
Read Story
How Will $2.6m Non-Dilutive Capital Accelerate Tryp’s TRP-8803 Trials?
8:37am on Tuesday 12th of August, 2025 AEST
Key Points
Secured $2.6m R&D loan facility from Rockford Equity
Facility repaid via future R&D tax incentives, non-dilutive capital
Strengthened cash reserves to over $3.8m including pending tax rebate
Funding to accelerate TRP-8803 clinical trials, including world-first BED study
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TYP
OPEN ARTICLE